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Spondylo-epimetaphyseal dysplasia Matrilin 3 type (SEMD) is a rare autosomal recessive 2 
skeletal dysplasia characterized by short stature, abnormalities in the vertebral bodies and long 3 
bones, especially the lower limbs. We enrolled a consanguineous family from Pakistan in which 4 
multiple siblings suffered from severe skeletal dyspla ia. The six affected subjects ranged in 5 
heights from 100 to 136 cm (~-6 standard deviation). Lower limb abnormalities with variable 6 
varus and valgus deformities and joint dysplasia were predominant features of the clinical 7 
presentation. Whole exome sequencing (WES) followed by Sanger sequencing identified a 8 
missense variant, c.542G>A, p.(Arg181Gln) in MATN3 as the genetic cause of the disorder. The 9 
variant was homozygous in all affected individuals while the obligate carriers had normal heights 10 
with no skeletal symptoms, consistent with a recessiv  pattern of inheritance. Multiple sequence 11 
alignment revealed that MATN3 domain affected by the variant is highly conserved in 12 
orthologous proteins. The c.542G>A, p.(Arg181Gln) variant is only the fourth variant in MATN3 13 
causing an autosomal recessive disorder and thus expands the genotypic spectrum. 14 
 15 




Spondylo-epimetaphyseal dysplasia (SEMD) are a rare het rogeneous group of disorders 18 
including more than twenty different conditions distinguished by a combination of clinical, 19 
radiological and molecular characteristics and have diff rent modes of inheritance (Cormier-20 
Daire, 2008; Anthony et al., 2015). Skeletal abnormalities are characterized by spinal, epiphyseal 21 
and metaphyseal anomalies. Variants in genes encoding Cartilage Oligomeric Matrix Protein 22 
(COMP), Collagen Type 2 Alpha 1 (COL2A1), Perlecan, 3'-Phosphoadenosine 5'-23 
Phosphosulfate Synthase 2 (PAPSS2), Transcription Initiation Factor Kinase (EIFKA3), 24 
Matrilin-3 (MATN3) and Matrix Associated Actin-dependent Regulator of Chromatin 25 
(SMARCAL1) cause SEMD (Borochowitz et al., 2004; Jackson et al., 2012a; Mortier et al., 26 
2019).  27 
 28 
A rare autosomal recessive form of SEMD is Spondylo-epimetaphyseal dysplasia Matrilin 3 29 
type. It is associated with abnormalities in the vertebral bodies and long bones, especially in the 30 
lower limbs; the changes involving both epiphyses and metaphyses. It is caused by biallelic 31 
variants in MATN3 (OMIM# 602109) (Borochowitz et al., 2004). MATN3 is located on 32 
chromosome 2 and consists of eight exons (Belluoccio et al., 1998). It encodes a modular protein 33 
Matrilin-3 which is found specifically in the extracellular matrix of cartilage (Wagener et al., 34 
2000).  It has a Willebrand Factor A-domain, four epid rmal growth factor (EGF) repeats and a 35 
coiled-coil carboxy terminal domain for oligomerization.  MATN3 can make homotetramers or 36 
heterotetramers with Matrilin-1. MATN3 also has a high affinity to bind with both COMP and 37 
type IX collagen which are two important extracellular matrix components in cartilage (Cotterill 38 
et al., 2005; Bell et al., 2012).  39 
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In the present study we used a whole exome sequencing approach to identify the causative 40 
variant of MATN3 in a consanguineous family with multiple individuals ffected by severe 41 
skeletal dysplasia.  42 
 43 
Methods 44 
Family recruitment and sample collection  45 
We recruited a Pakistani family PK-ST-KP-08 from Southern Punjab with multiple individuals 46 
affected with short stature and severe skeletal malformations. The ethical committee at 47 
Bahauddin Zakariya University, Multan and the IRB of School of Biological Sciences, 48 
University of the Punjab, Lahore approved this research. Written informed consents were 49 
obtained for all participants. Clinical data and raiographs were acquired. The full heights, the 50 
trunk sizes without the head sizes, the size of lower segment from hip bone to feet while standing 51 
and arm spans were measured for the affected individuals. Upper segment to lower segment 52 
(US/LS) ratios and arm span to height (AS/Height) ra ios were calculated. Blood samples were 53 
collected from one unaffected and six affected individuals. Genomic DNA was extracted from 54 
whole blood using sucrose lysis and salting out.  55 
Whole exome sequencing and data analysis 56 
Whole exome sequencing (WES) was completed on genomic DNA of proband V:18 (Macrogen 57 
inc, South Korea). The data was analyzed using wANNOVAR 58 
(http:/wannovar.usc.edu/index.php) to annotate the variants. Exonic and splice site variants with 59 
an allele frequency of less than 0.01 were retained. Missense variants were prioritized on the 60 
basis of in silico predictions from Sorting Intolerant From Tolerant (SIFT) (http://sift.jcvi.org/), 61 
PolyPhen-2 (http://genetics.bwh.harvard.edu/pph2/), Protein Variation Effect Analyzer 62 
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(PROVEAN) (http://provean.jcvi.org/index.php), Mutation Assessor 63 
(http://mutationassessor.org/), Mutation Taster 2 (http://www.mutationtaster.org/), Rare Exome 64 
Variant Ensemble Learner (REVEL) and ClinPred (https://bio.tools/ClinPred). Conservation of 65 
amino acids was checked using UCSC genome browser (https://genome.ucsc.edu/) and 66 
homologene (http://www.ncbi.nlm.nih.gov/homologene). Comparison between the human 67 
protein sequence of MATN3 and that of five most diverse vertebrate species, mouse, chicken, 68 
alligator, frog and zebrafish was completed by obtaining their sequences from Uniprot 69 
(https://www.uniprot.org/) and alignment with Clustal Omega 70 
(https://www.ebi.ac.uk/Tools/msa/clustalo/). Associated phenotypes of genes affected by 71 
variants were accessed from Online Mendelian Inheritance in Man (OMIM) 72 
(https://www.omim.org/). 73 
Sanger sequencing 74 
Candidate variant was validated on DNA of all available family members by Sanger sequencing. 75 
Primers were designed using Primer 3 (http://bioinfo.ut.ee/primer3-0.4.0/) based on the genomic 76 
sequence of MATN3 (NM_002381.5) to amplify the exon 2 region containing the candidate 77 
variant. PCR products were sequenced using Big Dye Terminator v.3.1 (ABI Thermo Fisher) on 78 
ABI 3730. The shortlisted variant allele frequency was checked in 50 ethnically matched 79 
controls and all public databases.  80 
Model building of proteins 81 
The three dimensional (3D) structures of wild-type and mutant MATN3 were generated 82 
computationally by obtaining amino acids sequences from Uniprot Knowledge Database. A 83 
homology modelling approach was employed to predict 3D structures of wild-type and mutant 84 
MATN3. The automated Swiss modeller (https://swissmodel.expasy.org/) was employed to 85 
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predict MATN3 structure. Two templates (1X6V & 1JDN) having sequence identity (78.20 and 86 
31.04%, respectively) were selected to build the models.  87 
 88 
Results 89 
Clinical characterization of patients 90 
The consanguineous family PK-ST-KP-08 included six affected individuals ranging in age from 91 
15 to 45 years (Figure 1A). All affected individuals had short stature (100 cm to 136 cm Z-scores 92 
-6.3 – -6.8), bowed legs and waddling gait (Figure 1B). Lower limb deformities predominated 93 
and varied from “windswept deformity” to varus or valgus deformity with flexion contractures at 94 
the knees (Figure 1B). No facial dysmorphism was observed. Radiographs of patients 1V:4, V:7 95 
and V:8 (Figures 1C and 1D) revealed severe joint dysplasia both at the knees and hips with 96 
abnormal metaphyseal shape at the distal femurs and femoral neck valgus or varus deformity. 97 
Femoral neck was short and the articular space reduced. The length of lower limb long bones 98 
was significantly reduced. Affected individuals IV:4, IV:6, IV:7, IV:8, V:7 and V:8 had heights 99 
of 123, 115,136, 131,130 and 100 cm with around -6.0 standard deviations (SD) for all. Their 100 
trunk sizes were 46, 51, 43, 44, 43 and 45 cm, ranging from -2.0 to -6.0 SD while the arm spans  101 
were 152, 157, 160, 150, 135 and 136 cm. Trunk size to lower segment ratios ranged from 0.7 to 102 
1.1 and arm span to height ratios were above 1.0 (1.1 to 1.3). Reduced trunk size to lower 103 
segment ratios suggested short trunks and increased arm span to height ratios were consistent 104 
with height deficit due to short trunk and lower limb abnormalities. Obligate carriers (IV:2, IV:5 105 
and V:6) had normal heights 155 to 164 cm with -0.8to -2.0 SD and no skeletal deformities were 106 
observed.  107 
Molecular genetic diagnosis 108 
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Filtration of whole exome sequencing based on allele fr quencies and homozygosity identified 109 
forty-eight variants for further analysis (Table S1). Since a number of these variants were also 110 
present in the homozygous condition in the public databases (gnomAD; 111 
https://gnomad.broadinstitute.org/ and ExAC; (http://exac.broadinstitute.org/), eliminating these 112 
reduced the list to seventeen variants (Table S1). Further scrutiny removed variants which were 113 
predicted to be benign by multiple software or the aff cted amino acids were not conserved in 114 
evolution. Finally, a MATN3 nonsynonymous variant c.542G>A, p.(Arg181Gln) (rs778152107), 115 
(Figure 2A), located in exon 2, remained which segregated with the disease phenotype. Sanger 116 
sequencing revealed that the variant was homozygous in all affected members and heterozygous 117 
in the unaffected individual in the pedigree (Figures 1A and 2A) while DNA from unaffected 118 
individuals IV:1, IV:3, IV:9 and IV:10 were not avail ble for analyses. The variant was not 119 
observed in 100 normal control chromosomes and was absent from South Asian population in 120 
the public databases.  Rare carriers of the variant were present in the public databases with an 121 
overall allele frequency of 0.000008 (TOPMED) 0.00012 (gnomAD_exomes) and 0.000017 122 
(ExAC), with no individuals homozygous for the variant. The variant was predicted to be 123 
damaging by all five software used; a SIFT score of 0.001 and Polyphen2 HDIV score of 1 were 124 
obtained which support the pathogenicity of the variant. However, the interpretation by ACMG-125 
AMP guidelines for the variant was "uncertain significance" (InterVar automated) but by adding 126 
the parameters that the variant segregates with phenotype and that the observed phenotype is 127 
consistent with the known disorder for the gene, it was predicted to be “likely pathogenic” 128 
(PM1, PM2, PP1, PP3, PP4 criteria) (InterVar adjusted).The variant has been submitted to the 129 
public database LOVD with variant ID  # 0000600857. 130 
Protein structure analyses 131 
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Computational three dimensional analyses revealed no difference in structure of the MATN3 132 
protein with the variant in comparison to that of the wild-type protein (Figures 2B). 133 
 134 
Discussion 135 
MATN3 plays an important role in assembling networks with other proteins and stability of cells 136 
in extracellular matrix of cartilaginous tissues. The Von Willebrand factor type A domain of 137 
MATN3 is encoded by exon 2. It has about 200 amino acids. This domain functions in bridging 138 
MATN3 with different proteins and facilitates oligomerization, filamentous network formation, 139 
cell attachment and scattering (Whittaker & Hynes, 2002; Mabuchi et al., 2004). The amino acid 140 
Arg181, affected by the variant identified in this study, is conserved in all vertebrate species 141 
(Figure 2C).  Although, it was hypothesized that the variant may affect the structure of MATN3, 142 
no difference between computational three dimensional structures of wild-type and mutant 143 
protein were predicted (Figures 2B). Therefore, it is postulated that the variant may affect the 144 
oligomerization or binding properties of MATN3, whic  remains to be determined 145 
experimentally. 146 
 147 
Variants of MATN3 are associated with two allelic disorders. Multiple epimetaphyseal dysplasia 148 
(MED; OMIM# 607078) is caused by heterozygous variants, while spondylo-epimetaphyseal 149 
dysplasia MATN3 type occurs due to homozygous variants of MATN3. Most of these variants 150 
causing both disorders are located in exon 2 which encodes von Willebrand factor A domain 151 
(Mostert et al., 2003). This is a strong indication of its vital role in MATN3 function (Mabuchi et 152 
al., 2004). About twenty-three heterozygous dominantly i herited pathogenic variants in MATN3 153 
have been reported to cause Multiple epimetaphyseal dysplasia MED (Chapman et al., 2001; 154 
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Mostert et al., 2003; Stefansson et al., 2003; Borochowitz et al., 2004; Jackson et al., 2004; 155 
Mabuchi et al., 2004; Cotterill et al., 2005; Maeda et al., 2005; Kim et al., 2011; Jackson et al., 156 
2012b). These variants cause phenotypes of mild short tature (SD 0 to -2.5) and bowed legs 157 
along with bilateral coxa vara, irregular acetabulum, knees with genu valgum and other 158 
ossification deformities of femur (Mabuchi et al., 2004; Jackson et al., 2004; Mäkitie et al., 2004; 159 
Bonafé et al., 2014).  160 
 161 
In contrast to multiple epimetaphyseal dysplasia, only three variants in MATN3 have been 162 
associated with a recessive mode of inheritance of Sp ndylo-epimetaphyseal dysplasia in 163 
Arabian, Japanese and Indian families (Borochowitz et al., 2004; Jackson et al., 2004; 164 
Shyamasundar et al., 2019). The missense variants c.973T>A p.(Cys304Ser) and c.359C>T 165 
p.(Thr120Met) were homozygous in affected individuals from Arabia and India, respectively 166 
(Borochowitz et al., 2004; Shyamasundar et al., 2019). The previously reported c.359 C>T 167 
p.(Thr120Met) variant was identified with c.908C>T p.(Thr393Met) variant in compound 168 
heterozygosity in a Japanese family (Jackson et al., 2004). Due to lack of skeletal phenotypes in 169 
obligate carriers of recessively inherited mutations, it has been postulated that these variants of 170 
MATN3 cause loss of function, while dominantly inherited heterozygous variants act by altering 171 
protein function in a dominant-negative way (Borochwitz et al., 2004).    172 
In conclusion, we present a novel missense variant of MATN3. This is the fourth report of an 173 
autosomal recessive Spondylo-epimetaphyseal dysplasia Martilin 3 type due to a MATN3 variant. 174 
Our findings, together with previous reports, emphasize that recessively inherited variants of 175 
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Figure 1 Pedigree and clinical manifestation of family PK-STKP-08. 268 
A. Pedigree of family PK-ST-KP-08 in which skeletal dysplasia is recessively inherited. 269 
Black symbols represent affected individuals. Genotypes for the variant c.542 G>A 270 
p.(Arg181Gln) are shown in the pedigree, below the symbols for each participant. 271 
B. Affected individuals IV:4, V:7 and V:8 showing their bowed legs.  272 
C. Radiographic features of knees in three patients (IV:4, V:7 and V:8). Common 273 
radiographic features in two patients are small and broad epiphyses of the knees.  274 
D. Radiographic features of pelvis in three patients (IV:4, V:7 and V:8). Common 275 
radiographic features in two patients are short and flattened femoral neck and crescent 276 
shape femoral head.  277 
 278 
Figure 2 Chromatogram, Clustal Omega alignment and predicted protein structure of MATN3. 279 
A. Chromatogram for MATN3 selected region showing c.542 C>T transition. The arrow 280 
indicates the point of variant. Reverse complement s quence is shown.  281 
B. Predicted protein structure for wild-type and mutant MATN3. (Colored images may be 282 
observed in the online issue). 283 
C. Multiple sequence alignment of MATN3 from diverse vertebrates showing p. Arg181 284 
(shown in bold) conservation. Stars represent the fully conserved amino acids which are 285 
identical in all species. Colons denote conservation between amino acids of similar 286 





• We describe a novel homozygous variant in MATN3 
• Biallelic MATN3 variant causes SEMD in six patients of a family 
• The carriers had no skeletal abnormalities, ruling out dominantly inherited MED 
• This is only the fourth report of SEMD due to MATN3 variant 
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Table S1 Variants revealed after whole exome sequence analysis and sorting
Chr Start End Ref Alt Func.refGeneGene.refGeneExonicFunc.refGene 1000G_ALLPROVEAN_pred
chrX 1,41E+08 1,41E+08 - AGAGT exonic MAGEC1 frameshift insertion . .
chr12 53207583 53207583 - CACCAAAGCCACCAGTGCCGAAACCAGCTCCGAAGCCGCCGGexonic KRT4 nonframeshift insertion. .
chr5 39202640 39202640 A C exonic FYB nonsynonymous SNV 0,0002 N
chr3 49162003 49162003 G A exonic LAMB2 nonsynonymous SNV 0,0004 D
chr3 49136119 49136119 C G exonic QARS nonsynonymous SNV 0,0004 N
chr17 42476569 42476569 C T exonic GPATCH8 nonsynonymous SNV 0,0002 .
chrX 56592021 56592021 C T exonic UBQLN2 nonsynonymous SNV . N
chr5 13789023 13789023 C G exonic DNAH5 nonsynonymous SNV . N
chr2 20205753 20205753 C T exonic MATN3 nonsynonymous SNV . D
chrX 1,53E+08 1,53E+08 C T exonic PLXNB3 nonsynonymous SNV . N
chr19 56424288 56424288 A G exonic NLRP13 nonsynonymous SNV 0,0004 N
chr3 47164891 47164891 C A exonic SETD2 nonsynonymous SNV 0,0002 N
chr3 49054875 49054875 G A exonic DALRD3 nonsynonymous SNV 0,0004 N
chrX 1,01E+08 1,01E+08 C T exonic ARMCX4 nonsynonymous SNV . .
chr14 55474084 55474084 T C exonic WDHD1 nonsynonymous SNV . N
chr19 58352848 58352848 C T exonic ZNF587B nonsynonymous SNV . D
chr19 55085882 55085882 G A exonic LILRA2 nonsynonymous SNV 0,0004 N
chr17 40273315 40273315 T G exonic KAT2A nonsynonymous SNV 0,0016 N
chr17 40179733 40179733 C T exonic ZNF385C nonsynonymous SNV 0,0018 N
chr13 1,14E+08 1,14E+08 C A exonic MCF2L nonsynonymous SNV 0,0006 D
chr6 99323548 99323548 C T exonic FBXL4 nonsynonymous SNV 0,0008 N
chr3 1,22E+08 1,22E+08 C T exonic IQCB1 nonsynonymous SNV 0,001 N
chr14 75388058 75388058 G A exonic RPS6KL1 nonsynonymous SNV 0,0014 D
chr5 36269540 36269540 G A exonic RANBP3L nonsynonymous SNV . D
chrX 1,14E+08 1,14E+08 G A exonic RBMXL3 nonsynonymous SNV 0,0005 N
chr5 1,78E+08 1,78E+08 C T exonic COL23A1 nonsynonymous SNV . N
chr17 18659398 18659398 C T exonic FBXW10 nonsynonymous SNV 0,0014 D
chr3 1,96E+08 1,96E+08 G A exonic WDR53 nonsynonymous SNV . N
chr3 1,14E+08 1,14E+08 G A exonic ZNF80 nonsynonymous SNV . N
chrX 1,41E+08 1,41E+08 - TTTTGAGGGTTTTGCCCAGTCTCCTCTCCAGATTCCTGTGAGCCCCTCCTTCTCCTCCACTTTAGTGAGTATTTTCCAGAGTTCCCCTGAGAGAACTCAGexonic MAGEC1 stopgain . .
chr3 49940923 49940923 A G exonic MST1R synonymous SNV 0,0004 .
chrX 30255058 30255058 G A exonic MAGEB3 synonymous SNV 0,0005 .
chr5 55110843 55110843 A G exonic DDX4 synonymous SNV 0,0004 .
chrX 1,18E+08 1,18E+08 C T exonic DOCK11 synonymous SNV 0,0005 .
chr5 36166729 36166729 A G exonic SKP2 synonymous SNV . .
chrX 65819416 65819416 A G exonic EDA2R synonymous SNV . .
chrX 70602486 70602486 A G exonic TAF1 synonymous SNV . .
chrX 1,36E+08 1,36E+08 A G exonic ARHGEF6 synonymous SNV . .
chr14 62541899 62541899 C T exonic SYT16 synonymous SNV . .
chr19 54649507 54649507 C T exonic CNOT3 synonymous SNV 0,0006 .
chr17 39684437 39684437 G A exonic KRT19 synonymous SNV 0,001 .
chr3 47088007 47088007 A G exonic SETD2 synonymous SNV 0,0014 .
chrX 1,19E+08 1,19E+08 C T exonic NKAP synonymous SNV 0,0016 .
chr18 33744452 33744452 G A exonic ELP2 synonymous SNV 0,0008 .
chr3 45751064 45751064 A G exonic SACM1L synonymous SNV 0,0002 .
chrX 1,54E+08 1,54E+08 G A exonic PLXNA3 synonymous SNV 0,0008 .
chrX 64955167 64955167 G A exonic MSN synonymous SNV . .
chr3 57438720 57438720 G A exonic DNAH12 unknown 0,0006 .
chrX 50213340 50213363 GGTTCTGGGGCCGGCTCTGTGGCA- exonic DGKK unknown . .
Variants remaining after removing those homozygous in controls, non-conserved and predictions of being benign are shown in bold.
